We are monitoring the impact of COVID-19 on Europe Liver Disease Treatment Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 1652
Share on
Share on

Europe Liver Disease Treatment Market Research Report – Segmented By Treatment Modality, Disease Type and Country (United Kingdom, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands and Rest of Europe) - Industry Size, Share, Trends and Growth Forecast (2020 to 2025)

Pulished: February, 2020
ID: 1652
Pages: 145

Europe Liver Disease Treatment Market Size (2020 to 2025)

The size of the Liver Disease Treatment Market in the European region is expected to reach USD 3.62 billion by 2025 from USD 2.08 billion in 2020, growing at a CAGR of 11.56% during the forecast period.

The percentage of the aged population diagnosing with liver-related diseases is significantly increasing in Europe and is primarily driving the growth of the European liver disease treatment market. Europe is among one of the leading markets for Liver Disease Treatment Drugs. As per a report, liver cirrhosis causes 170,000 deaths in Europe annually. Within Europe, Germany, France, and the United Kingdom account for the largest liver disease treatment market share.

Various technological advancements in the imaging techniques, Y-O-Y increase in the patients diagnosing with the liver diseases further contribute to the growth of the market. The increasing number of mergers and acquisitions that are happening between the companies is predicted to shape the face of the market better during the forecast period. The license expiration of a few drugs and robust pipeline drugs for the treatment of liver diseases is adding fuel to the market.

Strict regulations of the FDA, MHRA in approving the new drugs, and high costs required for the development of new drugs, and the high costs associated with the treatment for liver diseases are expected to hamper the market growth to a specific limit.

This research report on the Europe Liver Disease Treatment Market has been segmented and sub-segmented into the following categories:

By Treatment Modality:

  • Antiviral
  • Vaccines
  • Chemotherapy
  • Immunosuppressive Agents
  • Corticosteroids

By Disease Type:

  • Hepatitis
  • Non-Alcoholic Fatty Liver Disease
  • Alcohol-Induced
  • Liver Cancer

By Country:

  • United Kingdom
  • France
  • Spain
  • Germany
  • Italy
  • Russia
  • Sweden
  • Denmark
  • Switzerland
  • Netherlands
  • Rest of Europe

Regional Analysis:

Geographically, the European liver disease treatment market stands second, following North America in leading the global liver disease treatment market. It is due to viral hepatitis, genetic disorders, unhealthy diet, and excessive intake of alcohol.

Germany, UK, and France account for significant shares of the liver disease treatment market in the region. The growing number of liver disease cases because of the vast drinking population in Europe and increasing obesity and growing new clinical needs in liver diseases are likely to accelerate market growth. The Germany market is rising due to factors like excess intake of over-the-counter high dosage drugs, reimbursement policies for liver diseases in the healthcare sector, government, and other private organizations bring out the awareness by organizing programs regarding liver disease treatment which propels the market during the analysis period. Alcohol consumption is considered to cause 20%-50%of cirrhosis of the liver, and around 13% of the population across the globe, i.e., more than 600 million adults, are obese according to World Health Organization. Moreover, Cirrhosis can cause 170,000 deaths in Europe every year.

Companies playing a vital role in the European Liver Disease Treatment Market profiled in the report are Gilead Science Inc. (U.S.), Pfizer Inc. (U.S.), Merck & Co. (U.S.), Johnson & Johnson (U.S.), Novartis (Switzerland), Roche (Switzerland), Sanofi-Aventis (France), Abbott Laboratories (U.S.), Bayer Schering AG (Germany) and AstraZeneca (United Kingdom).

1.Introduction                                                  

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                          

                1.4 General Study Assumptions                                

  1. Research Methodology

                2.1 Introduction                                               

                2.2 Research Phases                                      

                                2.2.1 Secondary Research                           

                                2.2.2 Primary Research                 

                                2.2.3 Econometric Modelling                      

                                2.2.4 Expert Validation                  

                2.3 Analysis Design                                         

                2.4 Study Timeline                                          

  1. Overview

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 Epidemology                                              

  1. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                                              

  1. Market Segmentation

                5.1 Treatment Modality                                               

                                5.1.1 Introduction                           

                                5.1.2 Antiviral                    

                                5.1.3 Vaccines                   

                                5.1.4 Chemotherapy                      

                                5.1.5 Immunosuppressive Agents                           

                                5.1.6 Corticosteroids                      

                                5.1.7 Others                      

                                5.1.8  Y-o-Y Growth Analysis, By Product                              

                                5.1.9  Market Attractiveness Analysis, By Product                            

                                5.1.10 Market Share Analysis, By Product                             

                5.2 Disease Type                                             

                                5.2.1 Introduction                           

                                5.2.2 Hepatitis                  

                                5.2.3 Non-Alcoholic Fatty Liver Disease                 

                                5.2.4 Alcohol Induced                    

                                5.2.5 Liver Cancer                            

                                5.2.6 Others                      

                                5.2.7  Y-o-Y Growth Analysis, By Type                    

                                5.2.8  Market Attractiveness Analysis, By Type                  

                                5.2.9  Market Share Analysis, By Type                    

  1. Geographical Analysis

                6.1 Introduction                                               

                                6.1.1 Regional Trends                    

                                6.1.2 Impact Analysis                     

                                6.1.3 Y-o-Y Growth Analysis                        

                                                6.1.3.1 By Geographical Area     

                                                6.1.3.2 By Product           

                                                6.1.3.3 By Type 

                                                6.1.3.4 By Application    

                                                6.1.3.5 By Indication       

                                6.1.4  Market Attractiveness Analysis                     

                                                6.1.4.1 By Geographical Area     

                                                6.1.4.2 By Product           

                                                6.1.4.3 By Type 

                                                6.1.4.4 By Application    

                                                6.1.4.5 By Indication       

                                6.1.5  Market Share Analysis                      

                                                6.1.5.1 By Geographical Area     

                                                6.1.5.2 By Product           

                                                6.1.5.3 By Type 

                                                6.1.5.4 By Application    

                                                6.1.5.5 By Indication       

                6.2 U.K                                 

                6.3 Spain                                             

                6.4 Germany                                     

                6.5 Italy                                               

                6.6 France                                          

7.Strategic Analysis                                                        

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                       

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services                              

                                7.2.5 Competitive Rivalry within the Industry                     

8.Market Leaders' Analysis                                                         

                8.1 Gilead Science Inc                                    

                                8.1.1 Overview                 

                                8.1.2 Product Analysis                   

                                8.1.3 Financial analysis                  

                                8.1.4 Recent Developments                       

                                8.1.5 SWOT analysis                       

                                8.1.6 Analyst View                          

                8.2 Pfizer Inc.                                    

                8.3 Merck & Co.                                               

                8.4 Johnson & Johnson                                 

                8.5 Novartis                                       

                8.6 Roche                                           

                8.7 Sanofi-Aventis                                          

                8.8 Abbott Laboratories                                               

                8.9 Bayer Schering AG                                   

                8.10 AstraZeneca                                            

9.Competitive Landscape                                                            

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                       

                9.3 Agreements, collaborations and Joint Ventures                                         

                9.4 New Product Launches                                         

10.Market Outlook and Investment Opportunities                                                          

Appendix                                                           

  1. a) List of Tables
  2. b) List of Figures
  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe Liver Disease Treatment Market, By Treatment Modality , From 2020 to 2025 (USD Billion)
  2. Europe Antiviral Market, By Region, From 2020 to 2025 (USD Billion)
  3. Europe Vaccines Market, By Region, From 2020 to 2025 (USD Billion)
  4. Europe Chemotherapy Market, By Region, From 2020 to 2025 (USD Billion)
  5. Europe Immunosuppressive Agents Market, By Region, From 2020 to 2025 (USD Billion)
  6. Europe Corticosteroids Market, By Region, From 2020 to 2025 (USD Billion)
  7. Europe Others Market, By Region, From 2020 to 2025 (USD Billion)
  8. Europe Liver Disease Treatment Market, By Disease Type, From 2020 to 2025 (USD Billion)
  9. Europe Hepatitis Market, By Region, From 2020 to 2025 (USD Billion)
  10. Europe Non-Alcoholic Fatty Liver Disease Market, By Region, From 2020 to 2025 (USD Billion)
  11. Europe Alcohol Induced Market, By Region, From 2020 to 2025 (USD Billion)
  12. Europe Liver Cancer Market, By Region, From 2020 to 2025 (USD Billion)
  13. Europe Others Market, By Region, From 2020 to 2025 (USD Billion)
  14. U.K. Liver Disease Treatment Market, By Treatment Modality , From 2020 to 2025 (USD Billion)
  15. U.K. Liver Disease Treatment Market, By Disease Type, From 2020 to 2025 (USD Billion)
  16. Germany Liver Disease Treatment Market, By Treatment Modality , From 2020 to 2025 (USD Billion)
  17. Germany Liver Disease Treatment Market, By Disease Type, From 2020 to 2025 (USD Billion)
  18. France Liver Disease Treatment Market, By Treatment Modality , From 2020 to 2025 (USD Billion)
  19. France Liver Disease Treatment Market, By Disease Type, From 2020 to 2025 (USD Billion)
  20. Italy Liver Disease Treatment Market, By Treatment Modality , From 2020 to 2025 (USD Billion)
  21. Italy Liver Disease Treatment Market, By Disease Type, From 2020 to 2025 (USD Billion)
  22. Spain Liver Disease Treatment Market, By Treatment Modality , From 2020 to 2025 (USD Billion)
  23. Spain Liver Disease Treatment Market, By Disease Type, From 2020 to 2025 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample